Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
McKesson
Mallinckrodt
AstraZeneca
Harvard Business School

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

SYLATRON Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: SYLATRON
Patents:30
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for SYLATRON
Recent Clinical Trials for SYLATRON

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Roswell Park Cancer InstitutePhase 2
Duke UniversityPhase 2
The Cleveland ClinicPhase 2

See all SYLATRON clinical trials

Pharmacology for SYLATRON

Company Disclosures: US Patents for SYLATRON

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering SYLATRON peginterferon alfa-2b VIAL 103949 009 2001-01-19   Start Trial Schering Corporation (Kenilworth, NJ) 2015-11-02 RX Orphan company
Schering SYLATRON peginterferon alfa-2b VIAL 103949 009 2001-01-19   Start Trial Enzon, Inc. (Piscataway, NJ) 2013-11-10 RX Orphan company
Schering SYLATRON peginterferon alfa-2b VIAL 103949 009 2001-01-19   Start Trial Enzon, Inc. (Piscataway, NJ) 2013-11-10 RX Orphan company
Schering SYLATRON peginterferon alfa-2b VIAL 103949 009 2001-01-19   Start Trial Schering Corporation (Kenilworth, NJ) 2015-11-02 RX Orphan company
Schering SYLATRON peginterferon alfa-2b VIAL 103949 009 2001-01-19   Start Trial Schering Corporation (Kenilworth, NJ) 2018-03-26 RX Orphan company
Schering SYLATRON peginterferon alfa-2b VIAL 103949 009 2001-01-19   Start Trial Schering Corporation (Kenilworth, NJ) 2018-03-26 RX Orphan company
Schering SYLATRON peginterferon alfa-2b VIAL 103949 009 2001-01-19   Start Trial Hoffmann-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) 2019-11-19 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for SYLATRON

These patents were identified by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Medtronic
Mallinckrodt
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.